Literature DB >> 1615127

The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine.

W A Corrigall1, K B Franklin, K M Coen, P B Clarke.   

Abstract

Rats were trained to self-administer nicotine on a fixed-ratio schedule of reinforcement. Infusion of the nicotinic antagonist chlorisondamine into the cerebral ventricles produced a sustained reduction in nicotine self-administration compared to vehicle-treated controls. Lesions of the mesolimbic dopamine system were produced by microinfusion of 6-hydroxydopamine into the nucleus accumbens. Following production of the lesions, nicotine self-administration was markedly reduced for the 3-week test period; motor impairment did not appear to be responsible. Post mortem analysis of brain tissue showed that the lesion produced a pronounced decrease in dopamine content of the nucleus accumbens and the olfactory tubercle, and a small depletion in the striatum. These data demonstrate that the reinforcing effects of nicotine occur within the central nervous system, and that the mesolimbic dopamine projection plays an important role in these effects.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1615127     DOI: 10.1007/bf02245149

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  34 in total

1.  Immunohistochemical localization of neuronal nicotinic receptors in the rodent central nervous system.

Authors:  L W Swanson; D M Simmons; P J Whiting; J Lindstrom
Journal:  J Neurosci       Date:  1987-10       Impact factor: 6.167

2.  6-Hydroxydopamine lesions of the medial prefrontal cortex fail to influence intravenous self-administration of cocaine.

Authors:  M T Martin-Iverson; C Szostak; H C Fibiger
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

3.  Effect of nigrostriatal dopamine depletion on the post-training, memory-improving action of amphetamine.

Authors:  N M White
Journal:  Life Sci       Date:  1988       Impact factor: 5.037

4.  Persistent behavior at high rates maintained by intravenous self-administration of nicotine.

Authors:  S R Goldberg; R D Spealman; D M Goldberg
Journal:  Science       Date:  1981-10-30       Impact factor: 47.728

5.  Nicotine maintains robust self-administration in rats on a limited-access schedule.

Authors:  W A Corrigall; K M Coen
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

6.  Clinical evaluation of mecamylamine for withdrawal from nicotine dependence.

Authors:  F S Tennant; A L Tarver; R A Rawson
Journal:  NIDA Res Monogr       Date:  1984-03

7.  Nicotine indirectly inhibits [3H]dopamine uptake at concentrations that do not directly promote [3H]dopamine release in rat striatum.

Authors:  S Izenwasser; H M Jacocks; J G Rosenberger; B M Cox
Journal:  J Neurochem       Date:  1991-02       Impact factor: 5.372

8.  Distribution of alpha 2, alpha 3, alpha 4, and beta 2 neuronal nicotinic receptor subunit mRNAs in the central nervous system: a hybridization histochemical study in the rat.

Authors:  E Wada; K Wada; J Boulter; E Deneris; S Heinemann; J Patrick; L W Swanson
Journal:  J Comp Neurol       Date:  1989-06-08       Impact factor: 3.215

9.  Chlorisondamine blocks acquisition of the conditioned taste aversion produced by (-)-nicotine.

Authors:  C Reavill; I P Stolerman; R Kumar; H S Garcha
Journal:  Neuropharmacology       Date:  1986-09       Impact factor: 5.250

Review 10.  Brain dopamine and reward.

Authors:  R A Wise; P P Rompre
Journal:  Annu Rev Psychol       Date:  1989       Impact factor: 24.137

View more
  235 in total

1.  Ultrastructural localization of the alpha4-subunit of the neuronal acetylcholine nicotinic receptor in the rat substantia nigra.

Authors:  M M Arroyo-Jim nez; J P Bourgeois; L M Marubio; A M Le Sourd; O P Ottersen; E Rinvik; A Fairén; J P Changeux
Journal:  J Neurosci       Date:  1999-08-01       Impact factor: 6.167

Review 2.  Cognitive effects of nicotine: genetic moderators.

Authors:  Aryeh I Herman; Mehmet Sofuoglu
Journal:  Addict Biol       Date:  2010-04-29       Impact factor: 4.280

3.  Varenicline blocks nicotine intake in rats with extended access to nicotine self-administration.

Authors:  Olivier George; Allison Lloyd; F Ivy Carroll; M Imad Damaj; George F Koob
Journal:  Psychopharmacology (Berl)       Date:  2010-10-06       Impact factor: 4.530

4.  Smoking cessation and chronic pain: patient and pain medicine physician attitudes.

Authors:  W Michael Hooten; Kristin S Vickers; Yu Shi; Kaye L Ebnet; Cynthia O Townsend; Christi A Patten; David O Warner
Journal:  Pain Pract       Date:  2011-04-25       Impact factor: 3.183

5.  Age-dependent effects of nicotine on locomotor activity and conditioned place preference in rats.

Authors:  James D Belluzzi; Alex G Lee; Heather S Oliff; Frances M Leslie
Journal:  Psychopharmacology (Berl)       Date:  2004-01-22       Impact factor: 4.530

6.  Pharmacogenetics of smoking cessation: role of nicotine target and metabolism genes.

Authors:  Allison B Gold; Caryn Lerman
Journal:  Hum Genet       Date:  2012-01-31       Impact factor: 4.132

7.  Repeated nicotine administration robustly increases bPiDDB inhibitory potency at alpha6beta2-containing nicotinic receptors mediating nicotine-evoked dopamine release.

Authors:  Andrew M Smith; Marharyta Pivavarchyk; Thomas E Wooters; Zhenfa Zhang; Guangrong Zheng; J Michael McIntosh; Peter A Crooks; Michael T Bardo; Linda P Dwoskin
Journal:  Biochem Pharmacol       Date:  2010-03-25       Impact factor: 5.858

Review 8.  From smoking to lung cancer: the CHRNA5/A3/B4 connection.

Authors:  M R D Improgo; M D Scofield; A R Tapper; P D Gardner
Journal:  Oncogene       Date:  2010-06-28       Impact factor: 9.867

9.  Influence of tetrodotoxin and calcium on changes in extracellular dopamine levels evoked by systemic nicotine.

Authors:  M E Benwell; D J Balfour; H M Lucchi
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

Review 10.  Dopamine reward circuitry: two projection systems from the ventral midbrain to the nucleus accumbens-olfactory tubercle complex.

Authors:  Satoshi Ikemoto
Journal:  Brain Res Rev       Date:  2007-05-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.